Florida Cancer Institute ATI — New Port Richey, Florida

Florida Cancer Institute ATI is a clinical research site located in New Port Richey, Florida, United States 34655.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Florida Cancer Institute ATI has participated in 1 clinical trials.

Therapeutic areas: Non-Germinal B-Cell-like (GCB) Diffuse Large B-cell Lymphoma (DLBCL).

Sponsors: Millennium Pharmaceuticals, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Florida Cancer Institute ATI?

Florida Cancer Institute ATI has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Florida Cancer Institute ATI conducted?

Florida Cancer Institute ATI has 1 clinical trials on record. Their work covers Non-Germinal B-Cell-like (GCB) Diffuse Large B-cell Lymphoma (DLBCL).

Is Florida Cancer Institute ATI accredited by Crixeo Health?

Florida Cancer Institute ATI has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Florida Cancer Institute ATI?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.